Agilent Q2 Revenues Up 6 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market Monday that revenues for its fiscal second quarter increased 6 percent year over year.

For the three months ended Mar. 31, Agilent recorded $ 1.02 billion in revenues compared to $963 million in Q2 2015, and beating the average Wall Street estimate of $983.3 million. Excluding currency effects, its recently divested NMR business, and any other acquisition and divestitures, core revenue growth was 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.